Skip to main content
Top
Published in: Endocrine 2/2015

01-06-2015 | Endocrine Imaging

Bilateral adrenal incidentaloma caused by 21-hydroxylase deficiency in an adult

Authors: Sun Hee Kim, Ji Hyun Park

Published in: Endocrine | Issue 2/2015

Login to get access

Excerpt

A 46-year-old patient was referred to our hospital due to incidental detection of an intraabdominal mass on ultrasound during work-up for abdominal discomfort. When the patient was seen, she was asymptomatic with the exception of mild non-specific weakness experienced over the previous 3 years. There was no history of chronic disease or acute medical conditions. She had never menstruated, been married, or had children. The patient’s blood pressure was 95/65 mmHg. Her height was 156 cm and her weight was 65 kg; moderate hirsutism of the face and chin was observed. …
Literature
1.
2.
go back to reference I. Nermoen, J. Rorvik, S.H. Holmedal, D.L. Hykkerud, K.J. Fougner, J. Svartberg, E.S. Husebye, K. Lovas, High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency. Clin. Endocrinol. 75(6), 753–759 (2011)CrossRef I. Nermoen, J. Rorvik, S.H. Holmedal, D.L. Hykkerud, K.J. Fougner, J. Svartberg, E.S. Husebye, K. Lovas, High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency. Clin. Endocrinol. 75(6), 753–759 (2011)CrossRef
Metadata
Title
Bilateral adrenal incidentaloma caused by 21-hydroxylase deficiency in an adult
Authors
Sun Hee Kim
Ji Hyun Park
Publication date
01-06-2015
Publisher
Springer US
Published in
Endocrine / Issue 2/2015
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0405-9

Other articles of this Issue 2/2015

Endocrine 2/2015 Go to the issue

Endocrine Imaging

Marine-Lenhart Syndrome

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine